About this Study

DO YOU CARE FOR A CHILD, ADOLESCENT OR YOUNG ADULT WITH FRAGILE X?

People with Fragile X syndrome (FXS) often experience behavioral symptoms such as:

Anxiety — particularly social anxiety / avoidance

Irritability

Tantrums

Social unresponsiveness

The behavioral symptoms associated with a Fragile X diagnosis can create daily challenges for your child, your family and you. A clinical trial known as RECONNECT is currently enrolling participants to evaluate an investigational, topical treatment that may help improve Fragile X-related behavioral symptoms.

WHAT ARE THE RECONNECT STUDY QUALIFICATIONS?

3 - 29

YEARS OLD

Between the ages of 3 and 29

Diagnosed with FXS via genetic testing

Experiencing behavioral symptoms of FXS

In generally good health

WHAT IS THE STUDY MEDICATION?

The study medication is pharmaceutically produced cannabidiol (not extracted from the cannabis plant). It comes as a clear topical gel that is applied directly to the skin by rubbing into the upper arm and shoulder (like you would rub in sunscreen).

WILL A CANNABIDIOL TREATMENT CAUSE MY CHILD TO GET “HIGH”?

The study medication is pharmaceutically produced cannabidiol that contains no THC, which is the element of cannabis that causes a euphoric or “high” effect. Thus, there is no “high” experienced by children participating in the study.